Davidson Ateh

Biography

Davidson Ateh is an entrepreneurial executive with a successful track record of managing and financing disruptive early stage technology projects. He is the CEO of BioMoti where he raised over £1.5 million in non-dilutive and risk capital including securing a number of alliances. He is an inventor of and has progressed BioMoti’s innovative Oncojan™ cancer therapeutics platform, leading on preclinical development, clinical planning, financial modelling, market research, commercial plans, business development, venture pitching, regulatory compliance, staff, team building, external contractors and partnerships with major pharma companies. He has an interdisciplinary background in the physical and life sciences with a BEng in Biomedical Materials and a PhD in Bioengineering. He was a recipient of the prestigious Royal Society of Edinburgh/BBSRC Enterprise Fellowship during which he had a year of business training at the endowed Hunter Centre for Entrepreneurship of Strathclyde Business School.

Research Interest

Biomedical Materials.